The main outcomes of the second phase of the Rethinking Alzheimer's disease project will be presented by Prof. Dr. Sebastiaan Engelborghs, Full professor of neurology and neurosciences (Vrije Universiteit Brussel) and a co-chair of the Scientific Panel Dementia and Cognitive Disorders (European Academy of Neurology) in a scientific theatre Rethinking Alzheimer's Disease: From Diagnosis [...]
Walking the Talk for Dementia is an immersive experience that challenges conventional power dynamics and hierarchies in healthcare by using shared vulnerability as a catalyst for transformation. The third edition is set to take place from 24-31 August 2025 in Santiago de Compostela (Spain) under the overarching theme 'Rethinking the Future of Dementia'. It consists of [...]
The World Economic Forum (WEF)'s annual meeting in Davos, Switzerland has long been a leading gathering where global leaders in business, policymaking and activism converge to address critical international challenges. This year's meeting, held from January 20 to 24, 2025, focused on the theme "Collaboration for the Intelligent Age", with priorities including rebuilding trust, [...]
We are at a historical crossroads in the management of Alzheimer’s disease, with new treatments becoming available in various countries. For the first time in history, science is delivering new, potentially disease-modifying treatments for devastating diseases such as Alzheimer’s disease. However, the current healthcare system and regulatory frameworks do not [...]
The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), is very pleased to launch the "Rethinking Alzheimer's Disease Pathway: From Diagnosis to Care" Perspective Paper on the occasion of the World Alzheimer's Month. The aim of this report is not merely to document the status quo, [...]
We are pleased to announce that the second phase of the Rethinking Alzheimer's disease project kicks off! Rethinking Alzheimer's Disease, coordinated by EBC, in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), is a research-driven project offering policy recommendations to make tangible changes with the aim to improve the lives of [...]
The 36th Global Conference of Alzheimer’s Disease International (ADI) took place in Kraków, Poland from 24-26 April 2024, with ADI member Polskie Stowarzyszenie Pomocy Osobom z Chorobą Alzheimera (Polish Alzheimer’s Association). Held under the overarching theme of "Dementia: Insights. Innovations. Inspirations.", the conference brought together more than 1000 delegates from over 100 countries to share [...]
Side Event at the 2024 G7 Health Ministerial Meeting: Advancing Global Collaboration for Dementia and Healthy Aging EBC is pleased to collaborate with the Davos Alzheimer’s Collaborative (DAC), who will be hosting event on the sidelines of the 2024 G7 Health Ministerial Meeting: Advancing Global Collaboration for Dementia and Healthy Aging. The event [...]
EBC is pleased to be part of the session “Diagnosis, diagnostic tools and cognitive assessments” at the upcoming 36th Global Conference of Alzheimer’s Disease International. The session will take place on 26 April 2024 at 13:30-15:00 in Krakow (Poland). Prof. Giovanni Frisoni will present "Rethinking Alzheimer's disease: Scaling up health systems' readiness" as one [...]
EBC is pleased to hold a poster presentation "Rethinking Alzheimer’s disease: Cross-roads in the earlier detection and diagnosis of Alzheimer's" at the upcoming 36th Global Conference of Alzheimer's Disease International. The Conference will take place from 24-26 April 2024 in Krakow (Poland). The poster will be presented by Charlotte Teunissen, Professor in Neurochemistry, Chair [...]
